about
Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR methodEvaluation of iTRAQ and SWATH-MS for the Quantification of Proteins Associated with Insulin Resistance in Human Duodenal Biopsy SamplesImpact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity.Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementationGene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial.The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels.Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.Impact of dairy consumption on essential hypertension: a clinical study.DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trialsConsumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds.Effects of FADS and ELOVL polymorphisms on indexes of desaturase and elongase activities: results from a pre-post fish oil supplementation.Plasma Triglyceride Levels May Be Modulated by Gene Expression of IQCJ, NXPH1, PHF17 and MYB in HumansAssociation between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trialHigh-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humansClinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARĪ³ deficiency.Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation.Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.Expression and Sequence Variants of Inflammatory Genes; Effects on Plasma Inflammation Biomarkers Following a 6-Week Supplementation with Fish Oil.Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation.Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes.Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men - an exploratory study.A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism.Polymorphisms in Fatty Acid Desaturase (FADS) Gene Cluster: Effects on Glycemic Controls Following an Omega-3 Polyunsaturated Fatty Acids (PUFA) Supplementation.Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.Effects of the Mediterranean Diet before and after Weight Loss on Eating Behavioral Traits in Men with Metabolic Syndrome.Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.Impact of dairy products on biomarkers of inflammation: a systematic review of randomized controlled nutritional intervention studies in overweight and obese adults.It is time to revisit current dietary recommendations for saturated fat.Dietary fatty acids, dietary patterns, and lipoprotein metabolism.Correlates of reactive hyperemic index in men and postmenopausal women.Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.Comprehensive Review of the Impact of Dairy Foods and Dairy Fat on Cardiometabolic Risk.LDL particle number and size and cardiovascular risk: anything new under the sun?
P50
Q28143359-FC95E387-0E10-4E5D-8297-65920783831CQ28547099-19DE8372-A7BC-48B3-A86D-5F0ACDBC955CQ30620489-2FF83D29-7831-4C12-AE98-D18E42385701Q33604527-528C429B-FF68-44E6-B8B2-8244CF25B3A8Q33694013-D6927B23-6179-4504-820D-AB1D7B3F681DQ33804948-40228EB1-2D41-43EC-B403-529B757D0864Q33825102-E0FA37A2-33F1-45BC-A38F-42F8D0406D63Q34067492-843EAB1F-E6D2-433F-9E95-B570ED5BE0CCQ34087255-4D47A4C0-91D2-4ADD-9A84-F37AEAC9D640Q34297213-ECAC812A-8176-46F0-95D4-4092AF0B6553Q34469710-57B4A073-258F-408A-A6F9-B4CBCD1E84A7Q34534184-3E1E183E-E9A1-4902-A6DE-38959F7DE2C8Q34680636-B1A3F89D-134B-4C0B-A184-4D88564B2C9AQ35125145-40E77AC2-A610-48B6-ABE6-DDA089D8114DQ35136529-829ED6D3-52DA-4687-8F3A-052DB5349CECQ36145262-74BEAF44-9B19-4010-B047-A92C0E2E91D8Q36250306-33392B75-5CB7-4904-AD88-BB790B006DBDQ36330840-848B46A2-44E4-4DD6-AB7D-DD0E32E4BB3CQ36395720-4490DFDD-3F82-474B-B70A-830C9D40655DQ36462080-A0D306D7-4789-434E-A1EB-C64B80D4A2E6Q36680973-376F27E2-F178-4692-80D6-BDE6E5DC204DQ36743698-5329FA75-5F0D-4EF5-8F04-033EAD5D2C11Q36921867-A3B43DA3-EEBD-4C8D-85AA-31D35F1BE9FAQ36947521-1897F614-5241-4067-A637-8B7A9A547047Q37033222-75E8B873-CB31-4B93-8B4F-6F28CAD59BB4Q37082701-9D4A1FDE-A816-4376-94B0-3864F93502B4Q37288388-E5EFE864-F947-48EF-A0A8-EC549FC7F671Q37350799-68671879-CC9B-4267-B63F-445C3BE71C5DQ37585006-91BE786A-55A8-4BF9-8E96-B7BDF0AAA4BEQ37590276-71A22160-BCEB-48DF-9B80-BB783F747EEAQ37729893-4C06F6A9-DFEE-4E38-A10C-63CBE2BFCCD3Q37737551-64507DE2-BD86-4173-AB14-10DB616E7980Q38085243-F099BE1D-DEB4-4142-9910-A531837FC918Q38257894-B1C3595F-2655-4C3A-9024-BDB53B6B5382Q38304757-DEC241A3-4584-42C8-99E8-0DB99AEDD2E0Q38440350-440DF89E-6190-4C3D-BDCB-BC5894018548Q38440805-33402D12-8B6D-492C-9A0B-44A8BD3C23DBQ38682694-6868791B-6872-4368-8311-F0400BB9949DQ38763936-3809A9F2-CDD3-48F4-8E05-58A043FB24A4Q38810814-3FE0F303-D60E-4F6D-9259-5E0A0DE01EE9
P50
description
mƩdecin, chercheur et professeur d'universitƩ
@fr
physician, researcher and university professor
@en
name
Couture P
@nl
Patrick Couture
@en
Patrick Couture
@fr
type
label
Couture P
@nl
Patrick Couture
@en
Patrick Couture
@fr
altLabel
Couture P
@en
prefLabel
Couture P
@nl
Patrick Couture
@en
Patrick Couture
@fr
P69
P214
P1153
7006017343
P2038
Patrick_Couture
P21
P213
0000 0004 5176 9418
P214
P31
P496
0000-0002-8414-3847
P569
1964-01-01T00:00:00Z
P6634
patrick-couture-48064849